Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial : clinical research : heart failure and cardiomyopathies - Angermann, Christiane; Sehner, Susanne; Gerhardt, Louisa M. S.; Santos-Gallego, Carlos G; Requena-Ibanez, Juan Antonio; Zeller, Tanja; Maack, Christoph; Sanz, Javier; Frantz, Stefan; Ertl, Georg; Badimon, Juan J (European heart journal, 2025)
Online veröffentlicht: 05. Februar 2025